M.F. Reznikoff‐Etiévant

1.0k total citations
22 papers, 651 citations indexed

About

M.F. Reznikoff‐Etiévant is a scholar working on Hematology, Immunology and Genetics. According to data from OpenAlex, M.F. Reznikoff‐Etiévant has authored 22 papers receiving a total of 651 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Hematology, 13 papers in Immunology and 8 papers in Genetics. Recurrent topics in M.F. Reznikoff‐Etiévant's work include Platelet Disorders and Treatments (10 papers), Reproductive System and Pregnancy (8 papers) and Blood groups and transfusion (6 papers). M.F. Reznikoff‐Etiévant is often cited by papers focused on Platelet Disorders and Treatments (10 papers), Reproductive System and Pregnancy (8 papers) and Blood groups and transfusion (6 papers). M.F. Reznikoff‐Etiévant collaborates with scholars based in France, Switzerland and Hungary. M.F. Reznikoff‐Etiévant's co-authors include Jean‐Yves Muller, Jacques Milliez, Véronique Cayol, C. Kaplan, C Patereau, Annie Robert, B. Carbonne, Florence Coulet, D. Kay Blanchard and Nathalie Valentin and has published in prestigious journals such as Human Reproduction, British Journal of Haematology and BJOG An International Journal of Obstetrics & Gynaecology.

In The Last Decade

M.F. Reznikoff‐Etiévant

20 papers receiving 617 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M.F. Reznikoff‐Etiévant France 13 400 224 171 113 98 22 651
D. Ware Branch United States 7 183 0.5× 155 0.7× 46 0.3× 54 0.5× 36 0.4× 7 439
W. Würfel Germany 14 72 0.2× 353 1.6× 44 0.3× 165 1.5× 326 3.3× 57 683
Ghanima Maassarani United States 12 90 0.2× 289 1.3× 55 0.3× 148 1.3× 318 3.2× 14 742
R.M.F. van der Weiden Netherlands 11 81 0.2× 104 0.5× 21 0.1× 95 0.8× 107 1.1× 38 406
Xu-ming Bian China 10 68 0.2× 107 0.5× 109 0.6× 195 1.7× 102 1.0× 43 681
Bruce B. Feinberg United States 14 89 0.2× 390 1.7× 23 0.1× 400 3.5× 99 1.0× 24 638
Shigeki Shimada Japan 20 83 0.2× 707 3.2× 28 0.2× 254 2.2× 372 3.8× 41 970
S. Bussen Germany 13 34 0.1× 174 0.8× 31 0.2× 197 1.7× 170 1.7× 37 621
G. M. Stirrat United Kingdom 11 54 0.1× 431 1.9× 24 0.1× 316 2.8× 240 2.4× 24 827
Nathan Mordel Israel 15 36 0.1× 138 0.6× 32 0.2× 64 0.6× 214 2.2× 33 514

Countries citing papers authored by M.F. Reznikoff‐Etiévant

Since Specialization
Citations

This map shows the geographic impact of M.F. Reznikoff‐Etiévant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.F. Reznikoff‐Etiévant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.F. Reznikoff‐Etiévant more than expected).

Fields of papers citing papers by M.F. Reznikoff‐Etiévant

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.F. Reznikoff‐Etiévant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.F. Reznikoff‐Etiévant. The network helps show where M.F. Reznikoff‐Etiévant may publish in the future.

Co-authorship network of co-authors of M.F. Reznikoff‐Etiévant

This figure shows the co-authorship network connecting the top 25 collaborators of M.F. Reznikoff‐Etiévant. A scholar is included among the top collaborators of M.F. Reznikoff‐Etiévant based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.F. Reznikoff‐Etiévant. M.F. Reznikoff‐Etiévant is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Reznikoff‐Etiévant, M.F., et al.. (2015). Allo-Immune Thrombocytopenias, Definition of a Group at Risk; A Prospective Study1. Current studies in hematology and blood transfusion. 119–124. 2 indexed citations
2.
Reznikoff‐Etiévant, M.F., et al.. (2002). Low Vitamin B12 level as a risk factor for very early recurrent abortion. European Journal of Obstetrics & Gynecology and Reproductive Biology. 104(2). 156–159. 52 indexed citations
3.
Reznikoff‐Etiévant, M.F., Véronique Cayol, B. Carbonne, et al.. (2001). Factor V Leiden and G20210A prothrombin mutations are risk factors for very early recurrent miscarriage. British Journal of Obstetrics and Gynaecology. 108(12). 1251–1254. 30 indexed citations
4.
Reznikoff‐Etiévant, M.F., Véronique Cayol, B. Carbonne, et al.. (2001). Factor V Leiden and G20210A prothrombin mutations are risk factors for very early recurrent miscarriage. BJOG An International Journal of Obstetrics & Gynaecology. 108(12). 1251–1254. 74 indexed citations
5.
Reznikoff‐Etiévant, M.F., Véronique Cayol, Gen Zou, et al.. (1999). Habitual abortions in 678 healthy patients: investigation and prevention. Human Reproduction. 14(8). 2106–2109. 39 indexed citations
6.
Mansour, Islam, M.F. Reznikoff‐Etiévant, & A Netter. (1994). No evidence for the expression of the progesterone receptor on peripheral blood Iymphocytes during pregnancy. Human Reproduction. 9(8). 1546–1549. 22 indexed citations
7.
Reznikoff‐Etiévant, M.F., et al.. (1991). HLA Antigen‐Sharing in Couples With Repeated Spontaneous Abortions and the Birthweight of Babies in Successful Pregnancies. American Journal of Reproductive Immunology. 25(1). 25–27. 25 indexed citations
8.
Valentin, Nathalie, Jean‐Denis Bignon, D. Kay Blanchard, et al.. (1990). HLA-DRw52a is involved in alloimmunization against PL-A1 antigen. Human Immunology. 27(2). 73–79. 119 indexed citations
9.
Reznikoff‐Etiévant, M.F., et al.. (1989). Autoimmune investigations in recurrent spontaneous miscarriages. Journal of Reproductive Immunology. 15. 115–115.
10.
Szekeres‐Barthó, Júlia, M.F. Reznikoff‐Etiévant, P. Várga, et al.. (1989). Lymphocytic progesterone receptors in normal and pathological human pregnancy. Journal of Reproductive Immunology. 16(3). 239–247. 69 indexed citations
11.
Reznikoff‐Etiévant, M.F.. (1988). Management of Alloimmune Neonatal and Antenatal Thrombocytopenia. Vox Sanguinis. 55(4). 193–201. 50 indexed citations
12.
Reznikoff‐Etiévant, M.F.. (1988). Management of Alloimmune Neonatal andAntenatal Thrombocytopenia. Vox Sanguinis. 55(4). 193–201. 2 indexed citations
13.
Reznikoff‐Etiévant, M.F., Cynthia Kaplan, C Patereau, et al.. (1986). [Immunization against the ZWa (PLA1) platelet antigen: group at risk, prevention of complications. Apropos of 132 cases].. PubMed. 34(6). 783–7. 6 indexed citations
14.
Reznikoff‐Etiévant, M.F., et al.. (1986). La maladie abortive immunologique et son traitement par immunothérapie. Revue Franç aise de Transfusion et Immuno-hé matologie. 29(3). 135–148. 3 indexed citations
15.
Kaplan, C., et al.. (1985). ANTENATAL PLAl TYPING AND DETECTION OF GP IIb‐IIIa COMPLEX. British Journal of Haematology. 60(3). 586–588. 24 indexed citations
16.
MULLER, J, et al.. (1985). Les thrombopénies néonatales alloimmunes. Revue Franç aise de Transfusion et Immuno-hé matologie. 28(6). 625–641. 11 indexed citations
17.
Reznikoff‐Etiévant, M.F., et al.. (1984). HLA‐DR locus and maternal‐foetal relation. Tissue Antigens. 24(1). 30–34. 23 indexed citations
18.
Reznikoff‐Etiévant, M.F., et al.. (1983). Thrombopénies néo-natales par allo-immunisation anti-plaquettaire. Conduite à tenir.. La Presse Médicale. 12(9). 575–575. 1 indexed citations
19.
Reznikoff‐Etiévant, M.F., et al.. (1981). HLA‐B8 antigen and anti‐PLA1 allo‐immunization. Tissue Antigens. 18(1). 66–68. 38 indexed citations
20.
Reznikoff‐Etiévant, M.F., et al.. (1978). L'inhibition de la migration des plaquettesUne technique simple pour le groupage PLA1 et la recherche d'allo- et auto-anticorps anti-plaquettes. Revue Franç aise de Transfusion et Immuno-hé matologie. 21(5). 1103–1119. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026